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Viruses often induce signaling through the same cellular cascades that are activated by damage to
the cellular genome. Signaling triggered by viral proteins or exogenous DNA delivered by viruses
can be beneﬁcial or detrimental to viral infection. Viruses have therefore evolved to dissect the cel-
lular DNA damage response pathway during infection, often marking key cellular regulators with
ubiquitin to induce their degradation or change their function. Signaling controlled by ubiquitin
or ubiquitin-like proteins has recently emerged as key regulator of the cellular DNA damage
response. Situated at the interface between DNA damage signaling and the ubiquitin system, viruses
can reveal key convergence points in this important cellular pathway. In this review, we examine
how viruses harness the diversity of the cellular ubiquitin system to modulate the DNA damage sig-
naling pathway. We discuss the implications of viral inﬁltration of this pathway for both the tran-
scriptional program of the virus and for the cellular response to DNA damage.
 2011 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
The DNA damage response (DDR) consists of a coordinated net-
work of proteins that mediate recognition of damaged lesions, acti-
vate signal transduction pathways that alter cell cycle progression,
and initiate processes that repair the damaged DNA [1,2]. Post-
translational modiﬁcations, including phosphorylation, acetyla-
tion, methylation, SUMOylation, and ubiquitination, are utilized
to regulate protein function in the damage response [3–5]. These
modiﬁcations alter protein function, change protein stability,
mediate protein–protein interactions, and participate in recruit-
ment of proteins to speciﬁc locations during the damage response.
In addition to DNA double strand breaks (DSBs) in the cellular gen-
ome, viruses also activate the DDR [6,7], and the presence of viral
proteins can lead to dramatic changes to the pattern of these post-
translational modiﬁcations in infected cells. Viruses thus provide
powerful tools to understand the inner workings of the cell, to
identify key cellular regulators of fundamental cellular pathways,
and to reveal mechanistic insights into how these pathways can
be manipulated. Post-translational modiﬁcation of proteins by
members of the ubiquitin family is emerging as a key factor in
the cellular response to DNA damage and the maintenance of gen-
ome stability [8,9]. A diverse and dynamic ‘‘ubiquitin landscape’’ ischemical Societies. Published by E
an).found at DSBs and is intimately involved in recognition and signal-
ing of the DNA damage [8,10]. In this review we focus speciﬁcally
on the interplay between viruses and the DNA damage machinery,
and we highlight ways in which viruses exploit ubiquitin modiﬁca-
tions to manipulate host cell responses to virus infection and alter
the ubiquitin landscape.
1.1. Introduction to ubiquitination and the DDR
Modiﬁcation with ubiquitin and ubiquitin-like proteins is em-
ployed as a reversible signal to regulate a vast array of diverse cel-
lular processes. Covalent attachment of a single molecule of the
conserved 76 amino acid ubiquitin protein can alter substrate pro-
tein activity and localization. Modular ubiquitin-binding domains
(UBDs) that bind monoubiquitin or polyubiquitin chains non-cova-
lently can distinguish between different types of ubiquitin modiﬁ-
cation [11]. Through these interactions, ubiquitin can be utilized as
a marker for regulated degradation, and also for non-proteolytic
functions such as altered subcellular localization and signaling
[12].
Ubiquitination is achieved through a cascade of enzyme activi-
ties provided by the E1, E2, and E3 enzymes [13,14]. The ﬁrst step
in ubiquitination is activation by the ubiquitin activating E1 en-
zyme, which forms a thioester bond with ubiquitin. Activated
ubiquitin is then transferred to the ubiquitin-conjugating enzyme
E2. The E3 ligase mediates conjugation of ubiquitin to the substratelsevier B.V. All rights reserved.
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ubiquitin and an acceptor amino acid (normally lysine) in the tar-
get protein. A single ubiquitin molecule can be conjugated onto a
single residue within the substrate (monoubiquitination), or sev-
eral residues in a target can each be modiﬁed with one ubiquitin
molecule (multi-ubiquitination). Long polyubiquitin chains can
also be formed linked to a lysine in the substrate. The seven lysine
residues in ubiquitin can be used for conjugation and the linkage
usage has distinct consequences for the substrate protein. Poly-
ubiquitin chains of K48-linked ubiquitin molecules generally tar-
gets the substrate for proteasome-mediated degradation.
Specialized ubiquitin-binding domains recognize monoubiquitin
or polyubiquitin chains with K63 linkages, which signal for non-
degradative functions. Ubiquitination is a dynamic and reversible
process, and isopeptidases called deubiquitinating enzymes
(DUBs) can speciﬁcally cleave ubiquitin linkages.
The cellular DDR is a signal transduction cascade regulated by
post-translational modiﬁcations [3]. In general, the initial steps of
the cascade are marked by phosphorylation and acetylation, while
the subsequent steps are characterized by ubiquitination and
methylation, with ubiquitin chains playing an important role in
amplifying the signal. The primary signal kinases activated by
damage are the ataxia telangiectasia mutated protein (ATM), the
ATM and Rad3-related kinase (ATR) and the catalytic subunit of
DNA-dependent kinase (DNA-PKcs). DSBs in genomic DNA are ﬁrst
recognized and bound by the Mre11/Rad50/Nbs1 (MRN) sensor
complex or the Ku70/Ku80 proteins, which recruit ATM or DNA-
PKcs, respectively. One of the earliest ATM-induced phosphoryla-
tion events occurs at S139 on the histone variant H2AX. The phos-
phorylated H2AX, referred to as cH2AX, acts as a signal for
recruitment of downstream effectors. Phosphorylation marks are
recognized by phospho-binding modules, such as the forkhead-
associated domain (FHA) and the BRCT domain ﬁrst described in
the C-terminus of BRCA1 [15].
Phosphorylation of damage proteins at DSBs facilitates subse-
quent recruitment of proteins involved in regulatory ubiquitina-
tion. Phosphorylated Mdc1, a checkpoint mediator associated
with chromatin at damage sites, is bound by the FHA domain in
the RING ﬁnger protein RNF8 [16–18]. RNF8 recruits the E2 en-
zyme Ubc13 to mediate ubiquitination of proteins at the damage
site, including histones H2A and H2AX. The integral role of ubiqui-
tination in DSB repair is further highlighted by the fact that RNF8-
mediated ubiquitination is necessary but not sufﬁcient for the sta-
ble accumulation of downstream DNA repair proteins at DSBs. Con-
jugated ubiquitin accumulates at damage sites and is recognized
by a second ligase, RNF168, which contains motifs interacting with
ubiquitin (MIUs) that bind ubiquitin modiﬁcations at the DSB site
[19,20]. Although the mechanistic details are still being elucidated,
it appears that RNF168 acts downstream of RNF8 to enhance depo-
sition of ubiquitin signals on histone substrates at damaged DNA
and signaling chromatin remodeling events that expose the H4-
K20 dimethyl mark to which the mediator 53BP1 binds [21]. The
extent to which different ubiquitin linkages are used is not com-
pletely understood. Linkage speciﬁc antibodies have demonstrated
that K63 accumulates at the break [19,20], and it is likely that
many substrates and different linkages will ultimately be demon-
strated as part of the ubiquitination cascade. DSBs are eventually
repaired by homologous recombination (HR) or non-homologous
end joining (NHEJ) pathways.
1.2. Viruses and the DDR
It has recently emerged that many viruses induce signaling
through the same cellular cascades that are activated by DNA dam-
age to the cellular genome [6,7]. The DDR is triggered as a response
to the activities of viral proteins and by the exogenous DNA deliv-ered and replicated by viruses. Although some aspects of the cellu-
lar response may be harnessed and exploited by viruses, other
parts may need to be subverted to prevent detrimental outcomes
for virus infection. Therefore there is a precise dissection of the cel-
lular pathway during infection, and many viruses express proteins
that can manipulate the DDR.
There are multiple reasons why the cellular DNA damage re-
sponse could have detrimental effects on virus infection and would
need to be attenuated to ensure efﬁcient virus growth. These in-
clude (1) the impact of signaling on protein function and check-
point activation, (2) the recruitment of repressive factors, and (3)
the processing of viral genomic DNA. Since many viruses use the
host cell machinery for crucial steps in protein production, such
as transcription, splicing, RNA transport and translation, damage
signaling that disrupts these cellular processes will have an ad-
verse effect on virus production. Activation of damage signaling
also leads to arrest at cell cycle checkpoints which may need to
be overcome. Just as accumulation of cellular signaling and repair
proteins at DSBs in cellular chromatin leads to silencing of gene
expression and processing of DNA ends, recruitment of DDR pro-
teins to viral genomes can impact viral gene expression and DNA
replication. Damage recognition leads to histone modiﬁcations that
signal recruitment of repressive complexes, which suppress gene
expression, providing an intrinsic host barrier that must be over-
come during the initial steps of infection or reactivation from la-
tent state. Processing of viral genomes by the cellular DNA repair
machinery can limit virus replication. DNA resection at the ends
of viral genomes can interfere with replication from terminal lo-
cated viral origins. Processing can also result in ligation or recom-
bination at ends to form concatemers of viral genomes that are too
large to be packaged into virus particles. The DNA sequences at the
termini of viral genomes must therefore be protected from pro-
cessing and erosion. To overcome these intrinsic barriers, viruses
have evolved multiple strategies to exploit or counter the effects
of the cellular DNA damage machinery. Many of these approaches
involve hijacking the host ubiquitin–proteasome system to induce
targeted degradation of key effectors of the cellular DDR.
1.3. Using ubiquitination to manipulate the DDR
A number of excellent recent reviews have summarized ways in
which viruses interact with the ubiquitin–proteasome system
(UPS) to blunt immune responses and promote virus replication
[22–26]. Since the E3 ligases confer the majority of the substrate
speciﬁcity to the ubiquitination reaction cascade, it is normally this
step that is harnessed by viral proteins to target host factors. There
are two main types of E3 ligases: those with a HECT domain
(homologous to E6-associated protein C-terminus), and those with
RING (really interesting new gene) ﬁnger domains. The HECT E3s
have direct catalytic activity, whereas the RING E3s act more like
scaffolds to bring the E2 and substrates together to facilitate ubiq-
uitination. There are examples of virally-encoded proteins that
mediate ubiquitination via HECT domains, such as the E6 protein
of human papillomavirus (HPV), which functions with the proto-
typical E6-associated protein E6-AP [26]. There are also viral li-
gases that function via RING ﬁnger domains, such as the
immediate early protein ICP0 of Herpes Simplex Virus type 1
(HSV-1). The RING ﬁnger is required for the E3 ligase activity of
ICP0 and its substrates can be targeted through direct interactions
or via other post-translational modiﬁcations (see below). ICP0 uses
UbcH5a or UbcH6 as its E2s [27], a selection that appears to be spe-
ciﬁc as a number of other E2s are unable to substitute. Interest-
ingly, these two E2 proteins were originally identiﬁed as
facilitating the HPV E6–E6AP-induced degradation of p53.
The Cullin-RING ligases (CRLs) form the largest class of cellular
ubiquitin ligases and they consist of multisubunit complexes
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member together with a RING ﬁnger protein [28]. Many viruses en-
code adaptors that assemble with cellular CRLs into ligases that are
redirected towards novel substrates [29]. For example, the Adeno-
virus (Ad) E4orf6/E1b55K proteins assemble into a complex that
targets cellular proteins for ubiquitination and degradation
[30,31]. The E4orf6 protein recruits the Cullin complex through
an interaction with Elongins B and C [32], while the viral E1b55K
protein serves as the substrate recognition component [33]. Inter-
estingly, there is heterogeneity in the composition of the E3 ligases
assembled by the E1b55K/E4orf6 proteins from different Ad sero-
types, with either Cul2 or Cul5 being utilized [34]. In some cases
the E4orf6 protein alone can act as a CRL substrate adaptor, binding
directly to the substrate and targeting it for degradation in the ab-
sence of E1b55K [35].
2. Selecting key targets in cellular damage pathways
As intracellular parasites with small genome sizes, viruses have
often evolved to target key convergence points in the cellular path-
ways that they disrupt or exploit. In this way, examining the point
at which viruses intervene can identify hubs or reveal important
regulators of cellular functions. In the following sections we dis-
cuss several of these regulators in the DDR pathway that are tar-
geted by viral ubiquitin ligases (summarized in Fig. 1). Although
viruses can target common host pathways, they may adopt diver-
gent mechanisms to neutralize the host defenses in order to pro-
mote efﬁcient virus growth. Even among closely related viruses
with a single virus family, different strategies may be employedFig. 1. Viral interfaces with key nodes of the DNA damage signaling pathway. The
cellular response to DNA damage is initiated by proteins that sense the damage and
signal to mediator proteins. Mediator proteins reinforce the signaling by a cascade
of post-translational modiﬁcations including phosphorylation, acetylation, ubiqui-
tination, and SUMOylation, and there is extensive crosstalk between these
modiﬁcations. Together, signaling from these DNA damage response proteins
coordinate cell cycle arrest and DNA repair. All of these nodes are targeted by
viruses, underscoring the importance of gaining control of this pathway. Studying
where viruses interface with the DNA damage response will likely reveal new nodes
or regulators of this important cellular pathway. Abbreviations: Herpes Simplex
Virus type 1 (HSV-1), Human T-cell Lymphotropic Virus (HTLV-1), Simian Virus 40
(SV40), Human Immunodeﬁciency Virus 1 (HIV-1), Adenovirus (AAV), Minute Virus
Mice (MVM), Human Papillomavirus (HPV), Human Cytomegalovirus (HCMV),
Hepatitis C Virus (HCV).to target and inactivate DDR pathways and counteract cellular re-
sponses. In some cases, in addition to beneﬁcial consequences for
the virus, this targeting has consequences for cellular DNA damage
recognition and non-degradative ubiquitin signaling.
2.1. The MRN complex
The MRN complex is composed of proteins known as Mre11,
Rad50, and Nbs1. The MRN complex has numerous enzymatic
functions and plays a central role in the cellular DDR [36,37]. It
has been demonstrated to serve as a sensor of DSBs and is involved
in recruitment and activation of ATM at damage sites. The MRN
proteins bind to DNA and the complex can bridge DNA ends to
mediate repair of two molecules. The complex is also involved in
pathway choice for DNA repair processes. Homology-directed re-
pair requires resection at DSBs, and this is initiated by the MRN
complex, in combination with other cellular nucleases [38]. MRN
is also involved in the resection-dependent alternative NHEJ path-
way that is characterized by large deletions and the use of short
microhomologies.
The ﬁrst example of the MRN complex being a target for viral
manipulation came from our observation that levels of all three
proteins are reduced during infection with Ad5 [39]. We demon-
strated that the E1b55K/E4orf6 complex was necessary and sufﬁ-
cient, and that degradation was due to proteasome-dependent
turnover [39,40]. The E1b55K protein binds to the MRN complex,
and mutants can separate degradation of MRN from targeting of
other substrates [40–42]. Degradation is reduced by a trans-dom-
inant negative Cul5 or by shRNA to Cul5, suggesting that the E3 li-
gase recruited contains this cullin [34,43]. Ubiquitination has not
actually been demonstrated on any of the MRN components and
it is difﬁcult to determine which complex member is the direct tar-
get. Since the complex is unstable in the absence of any single pro-
tein, removing any one member may be sufﬁcient to inactivate its
functions. Infections in mutant cell lines suggest that Mre11 may
be the degradation substrate for the E1b55K/E4orf6 complex of
Ad5 [41]. Although most of the Ad serotypes can degrade MRN, this
may not be a conserved target of E1b55K/E4orf6 across all the fam-
ily members [34,44].
We have proposed that Ad degrades the MRN complex in order
to prevent its detrimental effects on processing of the viral gen-
ome. MRN restricts replication of the viral DNA genome [45–47]
and is required for joining viral genomes into concatemers [39].
Since multiple functions are attributed to the MRN complex, its
depletion through virally-targeted ubiquitination has a number
of consequences for functioning of the host cell DNA damage re-
sponse. We have shown that depletion of MRN by viral proteins re-
duces the ability to activate ATM and ATR signaling pathways, and
blunts checkpoint activation [40,48]. However, not all signaling
events are blocked during virus infection, and there are some Ad
serotypes that generate both ATM and ATR dependent phosphory-
lation signaling [44]. The importance of Ad gaining control of DNA
damage signaling is underscored by the fact that redundant or
alternative viral strategies also exist, some of which also employ
the cellular UPS. For example the E4orf6 protein of the Ad12 sero-
type recruits a Cul2/Rbx1/elonginC complex to promote proteaso-
mal degradation of TopBP1, which results in inhibition of ATR
activation [35].
The central role of MRN in sensing and responding to DNA dam-
age or aberrant DNA structures is highlighted by the number of
viruses that target the cellular complex [7]. In addition to Ad, the
levels of the MRN complex are also reduced at late times of infec-
tion for other viruses. In the case of infection with Simian Virus
Type 40 (SV40), the viral T-antigen (LT) recruits a Cul7-containing
ubiquitin ligase to facilitate the degradation of the Mre11 complex
[49], while Minute Virus of Mouse (MVM) and HSV-1 initially
2900 M.D. Weitzman et al. / FEBS Letters 585 (2011) 2897–2906recruit MRN proteins into viral replication compartments but later
induce Mre11 degradation [50,51].
2.2. The ligases RNF8 and RNF168
RNF8 is a RING ﬁnger ubiquitin ligase that also contains a phos-
pho-binding FHA domain. This combination of motifs allows RNF8
to serve as a molecular adaptor between phosphorylation- and
ubiquitination-dependent DNA damage signaling and identiﬁes
RNF8 as a central nexus in the DNA damage signaling pathway
[16–18,52,53]. The HSV-1 immediate early protein ICP0 degrades
RNF8, preventing recruitment of downstream DNA repair proteins
to incoming viral genomes or sites of cellular DNA damage [54,55].
RNF8 accumulates at damaged DNA via a phospho-dependent
interaction between its FHA domain and ATM-phosphorylated
TQXF motifs on the upstream mediator protein, Mdc1. ICP0 has
evolved to mimic this interaction by targeting FHA domain of
RNF8 via a similar phospho-dependent interaction (Chaurushiya
et al., unpublished). In the absence of ICP0, the catalytic activity
of RNF8 combined with the E2 conjugating enzyme Ubc13 results
in the ubiquitination of histone substrates such as H2A and H2AX
and these act as a platform for the accumulation of downstream
signaling and repair proteins such as RNF168, BRCA1 and 53BP1
[17–20,53]. In the presence of ICP0, RNF8 is degraded and the lev-
els of ubiquitinated H2A and H2AX are reduced, preventing the sta-
ble accumulation of downstream repair factors [54]. Interestingly,
ICP0 also targets RNF168 for ubiquitination and degradation,
underscoring the importance to the virus of gaining control of
the pathway at this point [54]. The fact that ICP0 degrades both
RNF8 and RNF168 raises the possibility that there may be separate
RNF8- and RNF168-dependent functions. For example, ICP0-medi-
ated degradation of RNF168 could guard against ampliﬁcation of a
mono-ubiquitination signal established by an RNF8-independent
mechanism. Interestingly, recent studies on transcriptional silenc-
ing in the DDR (see below) reveal that transcription in the presence
of a DSB requires the simultaneous depletion of both RNF8 and
RNF168, suggesting that the ligases are not redundant in this path-
way, and hinting at a possible reason ICP0 may need to degrade
both proteins.
2.3. Targets that affect chromatin and impact viral gene expression
Upon entering a cell, the primary objective of a virus is to set up
a favorable cellular environment for replication, and this requires
efﬁcient transcription from the viral genome. Gaining control of
the cellular transcription machinery and defusing any cellular
silencing mechanisms is therefore key to establishing a successful
infection. It is well recognized that transcription is often regulated
by chromatin modiﬁcations, and there is now evidence that chro-
matin changes in response to DNA damage have implications for
transcription. Since chromatinization plays an important role in
regulating gene expression from viral genomes [56], viral interac-
tions with the DDR may contribute to hijacking or avoidance of cel-
lular transcriptional programs.
The Tip60 tumor suppressor is a histone acetyltransferase in-
volved in transcriptional regulation, checkpoint activation, and
apoptosis [57]. It is recruited to DSBs [58] and is required for the
mobilization of cH2AX immediately after break induction. Tip60
acetylates H2AX on K5, which promotes ubiquitination events on
H2AX, facilitating release of cH2AX from chromatin and signaling
termination of the DDR [59,60]. Tip60 forms a stable complex with
ATM and acetylates it in response to damage, facilitating ATM acti-
vation by auto-phosphorylation [61]. Several viruses have been
shown to interact directly with Tip60 [62,63]. Most recently,
Tip60 has been found to bind to HPV promoters where it acetylates
histone H4, recruiting the cellular protein Brd4 to repress HPV E6expression [64]. The HPV E6 protein responds by targeting Tip60
for proteasome-mediated degradation, resulting in the de-repres-
sion of viral promoters [64].
As described above, the ligases RNF8 and RNF168 are chroma-
tin-modifying enzymes that are involved in the DDR. The contribu-
tions of RNF8, RNF168, and uH2A to transcriptional repression at
DSBs were recently analyzed using a ﬂuorescent transcriptional re-
porter system [65]. In this system, DSBs generated in the proximity
of a reporter cassette using a targeted nuclease resulted in tran-
scriptional repression that was dependent on ATM, RNF8 and
RNF168 and facilitated by ubiquitinated H2A. Interestingly, the
authors of this paper speculated that the DSB-induced transcrip-
tional silencing pathway may have evolved to defend the genome
against the uncontrolled transcription of foreign genomes resem-
bling DSBs, such as viruses [66]. Other links between RNF8 and
transcription come from studies with RNF8 null mice, where male
infertility results from loss of chromatin ubiquitination and defects
in global nucleosome removal [67]. This defect in nucleosome re-
moval was found to be attributable to a loss of H4K16 acetylation,
a histone modiﬁcation with known roles in transcriptional activa-
tion and the maintenance of euchromatin. These ﬁndings highlight
the potential consequences of RNF8 loss on crosstalk between
transcriptionally important histone modiﬁcations.
Recent ﬁndings have strengthened the links between DNA dam-
age, H2A ubiquitination, and gene silencing, with implications for
their manipulation by viruses. Although there is a clear contribu-
tion of RNF8 and RNF168 to H2A ubiquitination, the deposition
of uH2A as a repressive histone mark is more canonically catalyzed
by the polycomb group complex (PRC1) proteins Bmi1 and Ring1b/
RNF2/RING2. Recent work has identiﬁed Bmi1 as a DNA repair pro-
tein, and demonstrated that Bmi1 acts as an adaptor for targeting
RING2, the catalytic subunit of the heterodimer, to the sites of
damage [68,69]. The PRC1 complex is required for post-damage
mono-ubiquitination of H2A, and contributes to homology-medi-
ated repair of DNA breaks. While one of these studies reported that
recruitment of Bmi1 to sites of DNA damage was dependent on
RNF8 [68], the other suggested that Bmi1 and RNF8 acted in paral-
lel pathways to control H2A ubiquitination [69]. These observa-
tions highlight a potentially important parallel between viral
control of the processes of damage responses and transcription.
Since mono-ubiquitinated H2A is linked to gene silencing and is
enriched in silenced chromatin, its manipulation by HSV-1 ICP0
via degradation of RNF8 and RNF168 may represent an example
of a virus interfacing with DDR proteins in order to control tran-
scription. In animal models, ICP0 is required for efﬁcient escape
from latency [70,71] and in tissue culture systems, mutant viruses
unable to express ICP0 can be transcriptionally silenced and persist
for extended periods of time [72,73]. These quiescent viral gen-
omes are not permanently inactivated, since they can be reacti-
vated by superinfection with wild-type HSV or by providing ICP0
in trans [72–74]. This suggests that ICP0 controls a reversible
silencing mechanism, and it is possible that degradation of RNF8
and RNF168, together with the potential resultant loss of Bmi1
recruitment and uH2A, provides a functional link from cellular
mechanisms of transcriptional silencing to ICP0 roles in reactiva-
tion. Relevant to this discussion is the recent observation that
the PRC1 complex binds to the HSV-1 genome during latency,
when ICP0 is not expressed [75].
2.4. The NHEJ machinery to prevent genome processing
Viruses with linear genomes need somehow to prevent joining
together of viral genomes. Although the Ad genome is predomi-
nantly in a linear monomeric form during infection with wild-type
virus, in cells infected with viruses mutated in the early region E4
the viral DNA is joined into end-to-end concatemers [76]. Genomes
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joints reveals heterogeneous terminal deletions with no evidence
for the use of microhomology [77]. Concatemer formation requires
proteins involved in NHEJ and is not observed in cells with mutant
DNA-PKcs or DNA ligase IV [39,78]. The MRN complex is also in-
volved, possibly through processing of the viral ends and removal
of a covalently bound terminal protein. During wild-type Ad infec-
tion the genome remains linear and therefore the virus expresses
proteins that can block the NHEJ-mediated concatemers. In addi-
tion to targeting the MRN complex (discussed above), Ad serotype
5 employs a number of other strategies to limit NHEJ. The E1b55K/
E4orf6 proteins redirect the cellular Cul5 to assemble an E3 ligase
complex to mediate degradation of DNA ligase IV [79]. Prevention
of NHEJ activity may be a general requirement across the Ad virus
family. Recent studies comparing degradation substrates for the
E1b55K/E4orf6 complex from representative serotypes suggest
that DNA ligase IV is a conserved target of this E3 ligase [34,44].
This appears sufﬁcient to prevent joining of viral genomes into
concatemers by an NHEJ mechanism [44]. In the case of Ad5, it
has been shown that Cul5 is involved and the E1b55K protein binds
DNA ligase IV directly [79] with a requirement for the BRCT do-
main (T. Gilson and G. Ketner, personal communication). This high-
lights an interesting parallel with the ICP0-RNF8 interaction, in
which ICP0 binds RNF8 directly via the FHA domain on the sub-
strate. These two examples demonstrate ways that viruses have
evolved to mimic post-translational modiﬁcations on cellular bind-
ing partners of key DDR proteins in order to inﬁltrate this impor-
tant cellular pathway.
The activity of the E1b55K/E4orf6 viral complex has a general-
ized effect on NHEJ. In addition to blocking end-to-end joining of
viral genomes, the E1b55K/E4orf6 complex also inhibits NHEJ in
other non-viral substrates such as DSBs generated by ionizing radi-
ation, and RAG1/2 generated substrates in a V(D)J plasmid recom-
bination assay [78]. DNA-PKcs and DNA ligase IV have also been
proposed to play roles in circularization or processing of HSV-1
genomes. While DNA ligase IV/XRCC4 dependent processing has
been proposed to beneﬁt viral replication [80], DNA-PKcs inhibits
viral replication and is targeted for degradation by ICP0 [81]. The
signiﬁcance of ICP0-mediated targeting of DNA-PKcs is unclear,
although expression of ICP0 inhibited the formation of circular
genomes at early times post-infection, raising the possibility that
DNA-PKcs may normally serve to circularize incoming viral gen-
omes [82].
2.5. Tumor suppressors p53 and Rb
The classic examples of viruses overtaking key cellular path-
ways by targeting crucial nodes come from Rb and p53, which to-
gether form the crux of G1/S regulation. The Rb family of proteins
represses transcription of genes required for entry into S phase by
binding and inhibiting the E2F family of transcription factors, while
p53 serves as a break on G1/S transition in response to a variety of
stress signals, including DNA damage and viral infection. Thus it is
imperative for viruses to be able to modulate both Rb and p53 to
promote transition to S phase and prevent apoptosis of the infected
cell. Canonical studies have described the ability of viruses to inac-
tivate and/or degrade Rb and p53 through protein–protein interac-
tions, and more recent studies have shown that viruses can target
E2F and p53-responsive promoters directly to modulate transcrip-
tional events facilitating entry into and through S-phase.
Both Ad-E1A and SV40-LT form stable complexes with Rb,
inhibiting its ability to bind and inactivate E2F transcription factors
(reviewed in Reference [83]). The E7 protein of HPV and NS5A of
hepatitis C virus (HCV) can also degrade Rb through the UPS
[84,85], although they each use different methods to ubiquitinate
Rb. HPV-E7 assembles a Cul2-based ubiquitin ligase complex[86], while HCV-NS5A recruits the E6AP ubiquitin ligase to target
Rb for degradation [87].
These viruses often encode distinct proteins to target p53, or
downstream p53 transcriptional targets, to prevent G1/S arrest
and promote cell transformation. Degradation of p53 via the UPS
is employed by Ad-E1b55K/E4orf6 and HPV-E6, the mechanisms
of which have been extensively reviewed [25,88]. More recently
it has been shown that viral proteins can also directly target chro-
matin to modulate transcriptional programs contributing to trans-
formation. Ad-E4orf3 induces heterochromatin formation
characterized by H3K9 methylation on p53 target promoters,
which prevents p53 binding [89]. Thus even in the presence of sta-
bilized p53, its target genes remain silenced. Viruses can also mod-
ulate SUMO pathways to affect the SUMOylation status and
downstream functions of p53 (see below).
2.6. The APC and cell cycle
The anaphase-promoting complex/cyclosome (APC) is a multi-
subunit E3 ubiquitin ligase complex that acts as a central coordina-
tor of cell cycle, mediating the timely degradation of cyclins and
other cell cycle regulators to promote transitions through the dif-
ferent phases [90]. Substrate speciﬁcity of the APC is regulated
by Cdc20 and Cdh1, which associate with the APC at different
times to facilitate transition from G2 and early mitotic events
(Cdc20) through anaphase and late mitotic events and back into
G1 (Cdh1). For some viruses, it is imperative to maintain the cell
in G1/S in order to ensure availability of the cellular DNA replica-
tive machinery. For other viruses, nuclear breakdown due to ex-
tended G2/M delay can facilitate nuclear entry of pre-integration
complexes for integration into the host genome, or exit of newly
synthesized genomes into the cytoplasm for packaging. Therefore
the APC/C complex is an attractive target for viruses attempting
to modulate different stages of the cell cycle, and different viruses
target distinct subunits [91]. The Ad E4orf4 protein recruits an
inactivating phosphatase, PP2A, to the complex [92]. The APC has
been reported to be deregulated by several mechanisms during hu-
man cytomegalovirus (HCMV) infection, including virally-induced
phosphorylation of Cdh1 [93], and more recently by degradation
of the APC subunits APC4 and APC5 [94]. The APC is also targeted
by Tax protein of Human T-cell Lymphotropic Virus (HTLV), the
Vpr protein from Human Immunodeﬁciency Virus (HIV), and the
E6/E7 proteins of HPV [91]. The Hepatitis B virus X protein (HBX)
dysregulates the mitotic checkpoint by binding BubR1, thereby
disrupting the association between BubR1 and the APC activator,
Cdc20 [95]. Perhaps most interestingly, a poxvirus protein (PACR,
poxvirus APC/C regulator) has recently been shown to mimic the
role of the APC11 subunit that promotes its E3 ubiquitin ligase
activity [96]. While both APC11 and PACR have similar RING-H2
domains, a speciﬁc sequence variation in the PACR RING-H2 do-
main renders it unable to promote ubiquitin conjugation. PACR
can bind to the normal APC11 binding partner APC2, integrating it-
self into the APC and impairing APC ubiquitin ligase activity. PACR
integration into the APC thus leads to accumulation of normal APC
substrates and deregulated cell cycle that promotes viral growth.
In addition to cell cycle control, APC and Cdh1 also regulate the
DNA damage checkpoint response and DNA repair through degra-
dation of a growing list of substrates, linking their activity to main-
tenance of genomic integrity [97]. Inappropriate regulation of the
APC by viral proteins could therefore contribute to transformation
and tumorigenesis.
2.7. The DDB1/Cul4 ligase
Cul4 is unique among Cullins in that it is able to form a complex
with DDB1, a protein that was identiﬁed by its ability to recognize
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homology with any known Cullin adaptor [98]. DDB1 has been
implicated in regulation of cell proliferation, DNA repair, and geno-
mic integrity through targeted ubiquitination of key cellular regu-
lators. The HIV and simian immunodeﬁciency virus (SIV) accessory
protein Vpr speciﬁcally associates with DDB1/Cul4 through an
adaptor protein VprBP/DCAF1 (reviewed in Reference [99]). The
interaction of Vpr with DDB1/Cul4 is required for a number of
the Vpr functions, including G2 cell cycle arrest and activation of
the DDR [100,101]. Although some degradation targets have been
identiﬁed, it is unclear exactly how Vpr exploits DDB1/Cul4 to gain
control of the cell cycle and promote viral infection. However, it
appears that gaining control of the DDR pathway at the level of
the DDB1/Cul4 complex is important for several viruses. Murine
gamma herpesvirus 68 (MHV68) latency-associated protein M2
protein inhibits DNA damage-induced apoptosis by interacting
with both the DDB1 complex and ATM [102]. Other viral proteins
such as paramyxovirus SV5, HBX and woodchuck Hepatitis B virus
X protein (WHX) all hijack the DDB1/Cul4 E3 ligase complex, to
facilitate replication and promote degradation of proteins that re-
spond to interferon signaling and mediate antiviral responses.
Strikingly, structural analysis revealed that these diverse viral pro-
teins bind to DDB1 similarly, possibly by mimicking the cellular
DCAF adaptors [103]. These data are an example of how studying
conserved viral strategies can pinpoint key cellular regulators. In
this case, a structural element that is important for the assembly
of both cellular and virally hijacked DDB1/Cul4 E3 complexes
was identiﬁed [103].3. Regulating the effect of viral and cellular ubiquitin ligases
The E3 ubiquitin ligases can themselves be modulated by post-
translational modiﬁcations. There are many examples of cellular li-
gases that are regulated by phosphorylation, interacting proteins,
or conjugation by other ubiquitin-like proteins such as NEDD8.
These modiﬁcations can promote or prevent intermolecular and
intramolecular interactions, or can produce conformation changes
that regulate ubiquitination of substrates. E3 ligases can also be
regulated at the proteolytic level by degradation, in negative feed-
back loops induced by self-catalyzed ubiquitination or through the
activity of another ligase [104]. Ubiquitin modiﬁcation on ligases
and substrates can also be reversed by the deubiquitinating en-
zymes or DUBs.
3.1. Manipulating via deubiquitination
Several DUBs have already been implicated in regulating the
DDR [8]. Examples include BRCC36 that acts preferentially on
K63 linkages and is recruited to DSBs as part of the RAP80 complex
[105]. Other DUBs can also reverse chromatin ubiquitination at
DSBs, affecting formation of damaged-induced uH2A foci, possibly
by counteracting targets of the damage ligases RNF8 and RNF168
[20]. The USP16 enzyme also negatively regulates uH2A, with
implications for repression of transcription at DSBs [65]. Another
DUB, OTUB1, directly binds and inhibits the E2 Ubc13 by a mech-
anism independent of its catalytic isopeptidase activity [106].
These examples demonstrate the versatility of DUBs in controlling
ubiquitination at DSBs. Viruses could alter both the E3 ligases and
their respective DUBs, and thus disrupt the dynamics of ubiquiti-
nation at damage sites.
Ligases that undergo auto-ubiquitination can be stabilized
through removal of ubiquitin by DUBs. The RING-containing E3 li-
gase ICP0 from HSV-1 binds to the isopeptidase USP7, and this pro-
tects ICP0 from auto-ubiquitination in vitro [107]. There is a
reciprocal relationship between these two proteins: their interac-tion greatly increases the stability of ICP0, while ICP0 also targets
USP7 for ubiquitination and proteasome-dependent degradation
[108]. The Epstein Barr Virus (EBV) protein EBNA1 also interacts
with USP7 [109], suggesting that this isopeptidase may be com-
monly usurped by viruses. Similar situations may exist for related
viral E3 ligases and the balance between the two will have func-
tional consequences for virally-mediated control of ubiquitination
in the DDR. For example, USP7 is known to deubiquitinate several
emerging and established players in DDR responses and cell cycle
regulation including H2B, the H2A ubiquitin ligase RING2, p53,
Mdm2, and claspin. Regulation of USP7 by viruses may enable
ﬁne-tuning of ubiquitin signals on targeted cellular proteins and
may indirectly affect damage responses. For example a recent pa-
per reports that the DNA methyltransferase DNMT1, a co-repressor
that is recruited to DSBs where it stimulates DNA methylation, is
degraded through acetylation and ubiquitination, which is coun-
teracted by the DUB activity of USP7 [110]. This suggests that viral
interactions with USP7 could indirectly have an effect on methyla-
tion-dependent silencing mediated by DNMT1. Viruses could also
indirectly impact the steady-state levels of ubiquitination on sub-
strates through upregulation of cellular DUBs.
Several viruses encode their own DUBs or are able to increase
the activity of cellular DUBs [23]. Viral proteins possessing deubiq-
uitinating activity appear to be particularly common in herpesvi-
ruses, perhaps in part due to their larger genome size [111]. In
fact, all known herpesviruses sequenced to date contain homologs
of the ﬁrst identiﬁed herpesviral DUB, HSV-1 UL36 [112], and in
many cases these DUBs have been shown to be required for opti-
mal viral infection. UL36 resides in the tegument layer located be-
tween the nucleocapsid and the envelope [113], and is carried into
the infected cell, suggesting that candidate substrates may include
intrinsic anti-viral defense proteins encountered by the virus at the
earliest stages of infection. In the case of herpesviruses, these
intrinsic anti-viral defense proteins include ND10 components
and certain DNA repair proteins [55,114]. A tegument-delivered
viral counter that did not need to be expressed de novo would ap-
pear ideally placed to act at this level.
3.2. Manipulating via SUMOylation
Crosstalk between post-translational modiﬁcations such as
phosphorylation, ubiquitination, and more recently, SUMOylation,
has been shown to be important for the successful propagation of a
DNA damage response, primarily in mediating protein–protein
interactions [3,115]. As described above, viruses have evolved
mechanisms to take advantage of both phosphorylation and ubiq-
uitination pathways to modulate the cellular DDR. SUMOylation
has been implicated in multiple DNA repair pathways [115], and
its manipulation by viral proteins may alter DDR outcomes during
infection. SUMO proteins and their ligases accumulate at DSBs in
mammalian cells [116], where they promote repair and may in-
crease the activity of ubiquitin ligases [117]. Several viral regula-
tory proteins and transcriptional transactivators have been
shown to be SUMOylated, including the IE1 and IE2 of HCMV
[118,119], the BZLF1 and Rta proteins of EBV [120,121], and the
E1b55K protein of Ad [122]. While many of these proteins are
known to modulate DNA damage responses and/or cell cycle pro-
gression, the contributions of SUMOylation to these functions is
not as well understood.
Recent descriptions of the ﬁrst virally-encoded SUMO E3 li-
gases, both of which can target p53, highlight the importance of
inﬁltrating the SUMO pathway during infection. SUMOylation of
transcription factors has been shown both to activate and repress
their activities, and examples of both exist in the case of viral
SUMOylation of p53. The b-ZIP protein from Kaposi’s Sarcoma Her-
pes Virus (KSHV) is a SUMO E3 ligase that is SIM-dependent and
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and Rb as well as itself, and this function is critical for its ability to
activate the transcriptional capabilities of p53 and induce cell cycle
arrest [123]. The Ad E1B55K protein is also a SUMO1-speciﬁc E3 li-
gase that SUMOylates p53 in vitro, and promotes p53 SUMOylation
when expressed in cells [124]. This SUMOylation appears to cause
p53 to be retained at PML bodies, inhibiting its ability to localize to
promoters and activate transcription.
Thus it appears that many viral regulatory proteins, which have
previously been described to modulate the DDR, are also connected
to the SUMO pathway. It has recently been found that certain pro-
teins known to interface with the DDR pathway can identify tar-
gets by recognizing SUMO modiﬁcations on potential substrates
[125]. One cellular example is RNF4, a SUMO-dependent ubiquitin
E3-ligase implicated in maintenance of genomic stability
[126,127]. It has recently been found that ICP0, the ubiquitin ligase
from HSV-1, encodes SIMs and can target SUMOylated substrates
for ubiquitination and degradation (C. Boutell and R. Everett, per-
sonal communication). As we have discussed, ICP0 interacts with
the DDR pathway at multiple levels, including targeting of DNA-
PKcs, RNF8 and RNF168 for degradation. It will be interesting to
determine whether the SUMO-targeted ubiquitin ligase activity
of ICP0 also enables it to interact with SUMO-modiﬁed DDR pro-
teins. We expect future work to reveal that SUMO-based pro-
tein–protein interaction mechanisms will be integral for viruses
to target the DDR, as well as other SUMO-regulated signaling
pathways.4. Conclusion
Phosphorylation and ubiquitination are reversible post-transla-
tional modiﬁcations that play important signaling functions in the
cellular DDR and are both manipulated by viruses to aid infection.
Given the important roles recently revealed for ubiquitin and
SUMO in DNA damage and repair pathways, it is likely that many
more examples of their modiﬁcation will come from watching
how viruses inactivate the intrinsic antiviral function of the DDR.
Most of the examples we have discussed here come from viral
exploitation of ubiquitin to target cellular proteins for degradation.
It is likely that there will also be many examples of viruses har-
nessing non-degradative ubiquitin signaling pathways, but so far
very few of these have been uncovered.
In addition to repair of DSBs, there are additional wings of the
DNA damage network that also involve ubiquitin modiﬁcations.
These include the Fanconi anemia pathway that is used to repair
interstrand crosslinks during replication, and DNA damage toler-
ance to bypass replicative lesions [9]. Although we have focused
on manipulation of ubiquitination by viruses in the DSB sensing
and repair pathways, it is likely that links also exist with these
other repair systems. For example, it has already been demon-
strated that the Fanconi anemia pathway, which is associated with
replication stress and results in monoubiquitinated FancD2 reten-
tion in chromatin, is activated during Ad infection [128] and by
expression of viral oncogenes such as the LT from SV40 and the
E7 protein from HPV [129,130]. The replication processivity factor
PCNA also gets monoubiquitinated after DNA damage and leads to
the recruitment of damage-tolerant DNA polymerases required for
translesion synthesis. Since PCNA is involved in replication of some
viral genomes and is often recruited to viral replication centers, it
will be interesting to see whether its post-translational modiﬁca-
tions are affected during virus infections.
As with the role of ubiquitination in the DDR in general, ques-
tions remain about viral modulation of the DNA damage associated
ubiquitination, such as how it is regulated, what the relevant sub-
strates are, and the importance of different ubiquitin chain link-ages. The comparison across the Ad serotypes demonstrates that
closely related viruses within a single family can adopt different
strategies to inactivate DNA damage responses during infection.
It will be informative to characterize the full composition of the
E3 ligases assembled across a family of viruses, and to determine
how this deﬁnes the substrates that are targeted. It will also be
important to study how modiﬁcations render cellular proteins sus-
ceptible or resistant to viral-induced ubiquitination.
The function of post-translational modiﬁcations is often medi-
ated by speciﬁc recognition of the modiﬁcation by downstream
proteins that harbor modular effector domains. Covalent modiﬁca-
tion by ubiquitin and related proteins changes the surface proper-
ties of a protein and thus provides novel interaction sites. Ubiquitin
binding domains act as receptors that recognize the ubiquitin mark
[11]. Surprisingly, no examples of ubiquitin-binding domains have
yet been identiﬁed in viral proteins. SUMO mediates protein–pro-
tein interactions via SIMs on receptor proteins [131]. SIMs have re-
cently been identiﬁed in some viral proteins and these may play
roles in nucleating viral structures, in promoting transcriptional
activation, and in targeting SUMOylated cellular substrates for deg-
radation. Given the extensive SUMOylation that takes place at DNA
damage sites, it is likely that the SUMO mark on DDR proteins is
also exploited by viruses for manipulation of the cellular response.
One of the major challenges in the study of ubiquitination is to
identify substrates. Viral proteins have historically revealed many
key cellular regulators and have deﬁned important protein interac-
tions. Proteomic studies with viral proteins will help to deﬁne pro-
tein interaction networks involved in the cellular DNA damage
response and how they are perturbed during virus infection and
transformation. The molecular surfaces that mediate protein–pro-
tein interactions between virus and host may also be attractive tar-
gets for development of small inhibitors as novel antiviral
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